使用123I FP-CIT SPECT测定脑深部电刺激后帕金森病的侧别
研究纳入19例接受双侧丘脑底核脑深部电刺激的帕金森病患者,在基线、术后6个月和1年评估统一帕金森病评定量表第3部分和Hoehn-Yahr分期,并同期行123I FP-CIT DAT SPECT。结果显示DBS后症状侧别可发生改变,症状侧别与DAT侧别一致性良好至优秀,两者侧别指数显著相关,DAT侧别指数可判别症状侧别,作者认为DAT SPECT有助于DBS术后程控调整,但需大规模研究验证。
要点
- 19例PD患者中,基线时左侧主导11例、右侧主导6例、对称2例,DBS后1年内10例症状侧别发生改变。
- 症状侧别与DAT侧别一致性在基线、术后6个月和1年分别为加权κ=0.742、0.736和0.813。
- DAT侧别指数判别症状侧别的AUC在基线、术后6个月和1年分别为0.833、0.982和1.000。
核心结论
- DBS后症状侧别可发生改变,且与DAT SPECT评估的侧别良好相关。
- 使用DAT SPECT客观评估侧别可能有助于PD患者管理,尤其用于调整DBS程控以精细平衡术后不对称症状。
- 作者认为需要大规模研究验证该结果。
研究设计与样本
- 研究纳入19例接受双侧丘脑底核DBS的帕金森病患者。
- 在基线、DBS后6个月和1年评估UPDRS和Hoehn-Yahr临床评分。
- 患者在DBS前及DBS后6个月和1年接受123I FP-CIT DAT SPECT检查。
- 症状侧别指数基于UPDRS第3部分确定,DAT侧别指数基于DAT SPECT确定。
主要发现
- 基线时19例患者中左侧主导型11例、右侧主导型6例、对称型2例。
- 19例患者中10例在DBS后1年内症状侧别发生改变。
- 症状侧别与DAT侧别一致性在基线、6个月和1年分别为加权κ=0.742、0.736和0.813。
- 症状与DAT侧别指数在基线(r=0.542,P=0.02)、6个月(r=0.579,P=0.01)和1年(r=0.689,P=0.02)均显著相关。
- DAT侧别指数判别症状侧别的AUC在基线、6个月和12个月分别为0.833(P=0.045)、0.982(P<0.001)和1.000(P<0.001)。
临床怎么用
- 作者认为,使用DAT SPECT客观评估侧别可能有助于PD患者管理,尤其用于调整DBS程控以精细平衡术后不对称症状。
局限性
- 作者指出需要大规模研究验证该结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Symptom laterality is one of the main characteristics of Parkinson disease (PD) and reported to be associated with motor and nonmotor symptom severity and prognosis. This study aimed to evaluate the changes of laterality after deep brain stimulation (DBS) and the association between dopamine transporter SPECT using I FP-CIT (DAT SPECT) and symptom laterality in PD before and after DBS. METHODS: Nineteen patients with PD who received bilateral subthalamic nucleus DBS were enrolled. The clinical scores including Unified Parkinson Disease Rating Scale (UPDRS) and Hoehn and Yahr were evaluated at baseline, 6 months, and 1 year after DBS. Also, the patients underwent DAT SPECT before and 6 months and 1 year after DBS. Symptom and DAT laterality indices were determined based on the UPDRS part 3 and DAT SPECT, respectively. The association between DAT and symptom laterality was assessed at baseline and 6 months and 1 year after DBS. RESULTS: At baseline, 11, 6, and 2 among 19 patients had left-side-dominant, right-side-dominant, and symmetric motor symptom, respectively. Among 19 patients, there were 10 patients who showed changed symptom laterality within 1 year after DBS. The agreement between symptom laterality and DAT laterality was good to excellent at baseline and 6 months and 1 year after DBS (weighted κ = 0.742, 0.736, and 0.813). Furthermore, symptom and DAT laterality indices showed significant correlation at baseline (r = 0.542, P = 0.02), 6 months (r = 0.579, P = 0.01), and 1 year after DBS (r = 0.689, P = 0.02). Symptom laterality could be determined by DAT laterality index with areas under curve of 0.833 (P = 0.045), 0.982 (P < 0.001), and 1.000 (P < 0.001) at baseline and 6 and 12 months after DBS, respectively. CONCLUSIONS: The symptom laterality could be altered after DBS and was well correlated with laterality evaluated by DAT SPECT. An objective evaluation of laterality using DAT SPECT would be helpful for the management of patients with PD especially for adjusting the DBS programming for fine balancing of the asymmetric symptom after DBS. The large-scale study is warranted for validation of this result.
引用
- Park HR, Ha S, Lee DS, et al. Determination of Parkinson Disease Laterality After Deep Brain Stimulation Using 123I FP-CIT SPECT. Clin Nucl Med. 2020. PMID: 32108695. doi:10.1097/RLU.0000000000002955
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。